-
Blood Plasma Derivatives Market Set to Witness Significant Growth by 2025-2032 | Shire Plc., CSL Limited, Octapharma AG
15 Sep 2025 10:38 GMT
Blood Plasma Derivatives Market is estimated to valued USD 52.96 Bn in 2025 and expected to reach USD 98.69 Bn by 2032, growing CAGR of 9.3% from 2025 to 2032
BURLINGAME, CA, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- Coherent …
-
Plastic Surgery Expert Dr. James Shire Shares Tips and Considerations for Eyelid Surgery in HelloNation
11 Aug 2025 21:00 GMT
What should someone consider before choosing eyelid surgery?
CHATTANOOGA, TN, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- What should someone consider before choosing eyelid surgery? In a feature article for HelloNation, facial plastic …
-
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
31 Jul 2025 11:05 GMT
… HR roles at Abiomed and Shire. Kelley holds a bachelor’s … Medication Guide. About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical … ,390
$
885,051
APELLIS PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF …
-
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13 Jun 2025 11:00 GMT
… Chief Executive Officer of Tonix Pharmaceuticals. “Having successfully built Tonix … acquisitions from companies such as Shire, Roche, Novartis and Sanofi. … Investor Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862 …
-
CFOs On the Move: Week ending Oct. 31
01 Nov 2025 20:05 GMT
… held finance leadership roles at Shire Pharmaceuticals and International Rectifier. Elinoff succeeds …
-
<![CDATA[Solidifying Dupilumab’s Role in Eosinophilic Esophagitis Care, With Evan Dellon, MD, MPH]]>
28 Oct 2025 20:15 GMT
… , Ferring, GSK, Phathom, Regeneron Pharmaceuticals, Sanofi, Shire/Takeda,Target RWE, and …
-
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
15 Oct 2024 10:00 GMT
… Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer … by his co-founding of Shire Pharmaceuticals. He brings a wealth of …
-
KU undergraduates Kyra Schrock and Ian Shire receive Courtwright Awards
11 Apr 2025 15:23 GMT
… poster event.
Ian Shire
Ian ShireIan Shire is a senior from … incredibly powerful tool," Shire said. “My work focuses … have utility in DNA-related pharmaceuticals/disease monitoring, … stability towards native nucleases.”
Shire has submitted an abstract …
-
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
29 Oct 2025 22:00 GMT
… the Regenerative Medicine Division at Shire Pharmaceuticals, guiding strategic direction and driving … held senior roles at ISIS Pharmaceuticals, Forest Laboratories, and Upjohn Laboratories …
-
Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control
28 Oct 2025 12:00 GMT
KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™) drug- …
About
© 1995-2025